Joint pain and menopause: causes and solutions

Why menopause triggers joint pain

Much is said about hot flashes, less about joints. However, studies are clear: in a review published in the journal Maturitas, more than half of perimenopausal and menopausal women report arthralgia — joint pain without visible lesions. The large American SWAN study, which followed thousands of women during the transition, found joint pain or stiffness in approximately 6 out of 10 women by the end of perimenopause.

The reason is biological, not psychological. Your joints are living tissues, and estrogens play three protective roles in them:

First role: anti-inflammatory. Estrogens inhibit the local production of inflammatory cytokines in the synovial membrane. When they drop, low-grade inflammation sets in — hence these diffuse morning stiffnesses. Second role: trophic. Estradiol stimulates chondrocytes, the cells that produce cartilage, as documented by work published in Arthritis Research & Therapy. Third role: tissue hydration. Less estrogen means less hyaluronic acid in the synovial fluid — the joint is less "lubricated."

Recognizing menopausal arthralgia (and not confusing it with osteoarthritis)

This is the question my patients ask me most often in consultation: "Is it osteoarthritis?" Not necessarily. Hormonal arthralgia of menopause has its own unique signature: it is diffuse, symmetrical, and fluctuating. It commonly affects the fingers, wrists, knees, and shoulders — often on both sides — and is more pronounced in the morning, improving with movement.

Osteoarthritis, on the other hand, is a localized mechanical wear: a specific joint, pain that increases with exertion and subsides with rest. The two can coexist, but they do not call for the same response.

Joint pain during menopause: solutions that really work

The good news: unlike mechanical wear, hormonal arthralgia responds well to lifestyle changes. Three levers stand out in the literature.

Collagen, vitamin C, magnesium: what science says about supplements

Joint tissue is made mostly of type II collagen (cartilage) and type I (tendons, ligaments). However, collagen production drops sharply after menopause — up to 30% of bodily collagen lost in the first five years, according to available dermatological and connective tissue data.

This is where supplementation has a solid rationale. Randomized clinical trials conducted with hydrolyzed collagen peptides show a reduction in activity-related joint pain after 12 weeks of daily intake. Collagen peptides, once absorbed, provide chondrocytes with the specific amino acids (glycine, proline, hydroxyproline) they need — and seem to stimulate their synthesis activity.

Three cofactors deserve attention:

A point on dosage form: to reach clinically studied doses (5 to 12 g of collagen peptides per day), the liquid form is more realistic than capsules — you would have to swallow more than fifteen for the same dose. This is the choice we made at Nutremys, and it is detailed in our complete guide to marine collagen during menopause.

Signs that you might benefit from supplementation

Joint supplementation makes even more sense if you recognize yourself in several of these situations:

• Diffuse morning stiffness that appeared or worsened since perimenopause;
• Symmetrical pain in fingers, knees, or shoulders, fluctuating weekly;
• More frequent cracking, sensation of "dry" joints;
• Thinner skin and more brittle hair in parallel — signs of overall collagen deficiency;
• Low dietary intake of protein and fatty fish;
• Resumption of physical activity hindered by pain.

In all cases, a medical check-up is necessary if the pain is intense, localized, with swelling or redness. And for an overview of useful micronutrients at this life stage, consult our guide to essential vitamins during menopause as well as our complete guide to menopause symptoms.